• Complying with multiple data privacy regimes
• Information sharing networks between regulators, law enforcement bodies, financial institutions and money service businesses
• UK company ownership information
Molly McAllister
CMO
Banfield
Molly McAllister, DVM, MPH, leads the Veterinary function of Banfield Pet Hospital and is driven by her passion for preventive health and the development of future leaders in the veterinary profession. As chief medical officer, she ensures the culture, strategy, talent, and tools are in place to consistently deliver excellence in high-quality medicine in Banfield hospitals. Her top priorities are to continually advance medical quality across Banfield, to promote inclusive health and wellbeing for veterinary professionals, and to advance a future for the veterinary profession that centers on the human-animal bond. Dr. McAllister is the board president for the newly formed Diversify Veterinary Medicine Coalition, board secretary for the Human Animal Bond Association, and a board member of Pet Peace of Mind. She has a veterinary medical degree from Oregon State University’s College of Veterinary Medicine and a master’s degree in Public Health from the University of Minnesota. Dr. McAllister and her family have a Parson’s Russell Terrier, Jack, a mixed-breed dog, Bryan, two cats named Cascade and Teton, and a horse, Goose. She enjoys running, hiking, birdwatching, and travel.
Jessica May
Head
European Virtual Veterinary Care Association
Jenny Wolski
SVP, Omnichannel Experience
Petco
End the first day by discussing highly sensitive topics and unique challenges facing the industry, whilst sharing practical solutions with your peers off the record. All roundtables will be led by an industry expert and will take place simultaneously.
Roundtable: A
AML, Due Diligence and
Beneficial Ownership
Roundtable: B
Sanctions Implementation
and Violations
Roundtable: C
Anti-Bribery
and FCPA
Roundtable: D
ESG Supply Chains
Russell Wallace
Senior AML Compliance Manager
Vodafone Group
Practical insights on how to prepare and manage cross-border investigation and remediation process in the face of rapidly multiplying and overlapping risks
• How are investigations initiated by authorities in key jurisdictions?
• Gathering evidence: Legal privilege, data privacy laws and disclosure actions
• What do enforcement agencies and regulatory bodies require in respect of historic conduct and what will be considered as mitigating factors?
• Making a case for remediation: Decisive factors, procedural and law enforcement nuisances
Jerry Zeldis
Executive Vice President, Research and Development
NexImmune
Shiara Mutukisna
Head of Legal and Compliance and Data Privacy Officer
Roche Diagnostics APAC
Shiara Mutukisna is Head of Legal and Compliance and Data Privacy Officer, for Roche Diagnostics APAC. She has over 20 years experience in leading Legal, Compliance and Risk functions of global organizations across the APAC region, in the Pharmaceutical, and Medical Devices industries. Shiara has built compliance programs from the ground up, including developing the organizational infrastructure of the function and the individual skill development of compliance professionals. Shiara has created and managed local and regional corporate compliance programs and initiated projects including performing complex investigations, and other structural elements of a Corporate Compliance Program. Shiara is also a Privacy expert, who advises on European and APAC privacy regulations.
Dr. Chandni Bhan
UK Head of Risk
Morgan Stanley
Dr. Chandni Bhan is Global Head of quant research and Model Risk, and Head of risk for UK for Morgan Stanley Investment Management. Previously she held roles across the business as head of risk for MSIM EMEA, as well CRO for MSIM Ireland. She has more than 16 years of working in Finance, both in front office, as well as risk, with extensive buy side and sell side expertise. She earned her PhD in statistics & probability from Michigan State University, and as an experienced data scientist and risk officer, she has pioneered analytical systems to build a proactive and forward looking risk function, embedded in the business, that ensures we drive risk prudent growth for our clients. She is a member of EMEA operating committee, risk leadership group, and several other committees globally including as the chair for the global investment management model risk committee. She also hosts several diversity podcasts and webinars for the business and is passionate about building a culture of inclusion and innovation.